Kalaris Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-106.3M | $-106.3M | $26.0K | $44.0M |
| FY2022 | $-142.1M | $-142.1M | — | $41.3M |
| FY2023 | $-124.5M | $-124.5M | — | $40.8M |
| FY2024 | $-20.7M | $-20.7M | — | $895.0K |
| FY2025 | $-38.4M | $-38.6M | $200.0K | $1.9M |